Search filters

List of works by Muneer H Abidi

A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.

scientific article published on 11 August 2012

Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers

scientific article

Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.

scientific article published on 16 June 2012

Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial.

scientific article published on 23 December 2011

BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

scientific article published on 6 June 2015

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

scientific article published on 22 December 2016

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

scientific article published on 19 March 2015

CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma

scientific article published on 22 March 2013

Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors

scientific article published in July 2009

Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease

scientific article published on 01 April 2008

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.

scientific article

Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.

scientific article

High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.

scientific article

Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma

scientific article

Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.

scientific article

Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.

scientific article published on August 2010

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous

scientific article published on 11 May 2020

Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma

scientific article published on 16 April 2020

Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenophelate Mofetil Use for Gvhd Prophylaxis: A Large Retrospective Analysis

scholarly article by Zaid Al-Kadhimi et al published February 2013 in Biology of Blood and Marrow Transplantation

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma

scientific article

Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection:

scientific article published on 24 March 2012

Older patients with myeloma derive similar benefit from autologous transplantation.

scientific article

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study

scientific article

POEMS Syndrome Presentation with an Abscess within the Plasmacytoma-A Rare Case Report

scientific article

Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)

scientific article

Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis

scientific article published on 2 August 2016

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

scientific article published on 21 September 2016

Reduced intensity transplantation for metastatic renal cell cancer with 2-year follow-up

scientific article published on 01 July 2007

Salvage second hematopoietic cell transplantation in myeloma

scientific article

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

scientific article published on 17 November 2015

Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient

scientific article published in February 2006

Successful autologous stem cell collection with filgrastim and plerixafor after long-term lenalidomide therapy for multiple myeloma.

scientific article

Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant

scientific article published on 03 April 2014

Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.

scientific article

The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation.

scientific article

Paulina is supported by:

About Paulina

Help